 CAMBRIDGE, Mass., April 19, 2022 GLOBE NEWSWIRE -- Wave Life Sciences Ltd. Nasdaq: WVE, a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, and Sri Vaddeboina, PhD, Senior Vice President, Chemistry, Manufacturing and Controls, are scheduled to participate virtually in an analyst-led fireside chat at Chardans 6th Annual Genetic Medicines Cell Therapy Manufacturing Summit on Tuesday, April 26, 2022, at 2:30 p.m. ET. 